BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 1, 2007
View Archived Issues
Takeda looks back on FY2006
Read More
Positive preclinical results with combined anthrax and plague vaccine
Read More
Clinical studies of drugs for digestive diseases
Read More
New therapeutic options for cancer imparted in recent patents
Read More
Recent Schering and Vertex patents describe novel therapeutic agents for respiratory disorders
Read More
Recent GSK patent discloses novel agents targeting hepatitis C virus infection
Read More
Clinical data on lisdexamfetamine in ADHD detailed
Read More
Pooled data show efficacy and safety of agomelatine in major depressive disorder
Read More
Recent clinical trials in urological cancer
Read More
LCP-Tacro delivers higher bioavailability compared to Prograf
Read More
First-in-class GABA-enhanced antipsychotic safe and well-tolerated in phase I study
Read More
Improved efficacy of PhGalpha1 demonstrated in new preclinical studies
Read More
NICE recommends use of Champix on U.K.'s National Health Service
Read More
Orlistat GSK recommended for approval in E.U.
Read More
XMT-1001 begins phase I study in solid tumors
Read More
Novacea and Schering-Plough sign license agreement for Asentar
Read More
CeNeRx licenses rights to PharmaNess cannabinoid portfolio
Read More
LymphoStat-B begins second phase III trial for SLE
Read More
XL-647 studied in new phase II NSCLC trial
Read More
Canadian approval for Thelin
Read More
Vernakalant (iv) filed in Canada
Read More
Aeras Global TB Vaccine Foundation updates TB vaccine development progress
Read More
Twice-daily Zyflo CR receives FDA approval
Read More
Vantas progresses through E.U. mutual recognition procedure
Read More
FDA approves new formulation of FazaClo
Read More
